Operating Expenses Zmiana Data
AbbVie USD 11.11B 540M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Celldex Therapeutics USD 51.76M 9M 2023-12
CSL USD 5.19B 142.6M 2023-06
Dynavax Technologies USD 64.09M 311K 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Incyte USD 826.07M 121.75M 2023-12
Intrexon USD 22.32M 571K 2023-09
J&J USD 16.57B 435M 2023-12
Jiangsu Hengrui CNY 4.47B 23.85M 2023-09
Merck EUR 4.19B 143M 2023-09
Merck USD 16.56B 6.35B 2023-12
Northwest Biotherapeutics USD 16M 1.75M 2023-09
Novavax USD 312.62M 56.35M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Rigel Pharmaceuticals USD 32.6M 446K 2023-09
Veracyte USD 133.71M 11.86M 2023-12



Agenus Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.